EC Number   |
Cofactor |
Reference |
|---|
    1.1.1.145 | more |
no reaction with 3-acetylpyridine-adenine dinucleotide, nicotinamide-hypoxanthine dinucleotide, 3-acetylpyridine-hypoxanthine dinucleotide |
389376 |
| 1.1.1.145 | more |
no significant activity with NAD+/NADH |
684725 |
| 1.1.1.145 | NAD+ |
- |
2884, 2898, 389370, 389371, 389373, 389374, 389376, 389378, 389379, 389380, 389382, 389383, 389384, 389385, 389386, 389387, 389388, 389389, 389390, 389391, 389392, 389393, 389395, 389396, 389397, 389399, 389400, 389401, 389402, 656091, 656652, 656655, 662371, 667452, 668423, 670036, 670037, 693887, 699845, 700182, 700557, 740503, 740914, 740998, 741250, 741261, 741423, 763397 |
| 1.1.1.145 | NAD+ |
cysteinyl and histidyl at NAD+-binding site |
389369 |
| 1.1.1.145 | NAD+ |
more than 10fold as active as NADP+ |
389372 |
| 1.1.1.145 | NAD+ |
NADH forms hydrogen bond with Asp35 in the NADH-wild-type 3beta-HSD1 complex |
725612 |
| 1.1.1.145 | NAD+ |
optimum coenzyme concentration is 1.5 mmol/l |
763139 |
| 1.1.1.145 | NAD+ |
preferred |
389377 |
| 1.1.1.145 | NADH |
- |
662371, 669061, 699111 |
| 1.1.1.145 | NADP+ |
- |
389371, 389378, 389402, 684725 |
